Saunders A - Search Results

1

Rosiglitazone induces mitochondrial biogenesis in mouse brain.

Strum JC, Shehee R, Virley D, Richardson J, Mattie M, Selley P, Ghosh S, Nock C, Saunders A, Roses A. Strum JC, et al. Among authors: saunders a. J Alzheimers Dis. 2007 Mar;11(1):45-51. doi: 10.3233/jad-2007-11108. J Alzheimers Dis. 2007. PMID: 17361034

2

Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways.

Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA. Cogswell JP, et al. Among authors: saunders am. J Alzheimers Dis. 2008 May;14(1):27-41. doi: 10.3233/jad-2008-14103. J Alzheimers Dis. 2008. PMID: 18525125

3

Clusters of adjacent and similarly expressed genes across normal human tissues complicate comparative transcriptomic discovery.

Liu C, Ghosh S, Searls DB, Saunders AM, Cossman J, Roses AD. Liu C, et al. OMICS. 2005 Winter;9(4):351-63. doi: 10.1089/omi.2005.9.351. OMICS. 2005. PMID: 16402893

4

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone.

Akuffo EL, Davis JB, Fox SM, Gloger IS, Hosford D, Kinsey EE, Jones NA, Nock CM, Roses AD, Saunders AM, Skehel JM, Smith MA, Cutler P. Akuffo EL, et al. Among authors: saunders am. Biomarkers. 2008 Sep;13(6):618-36. doi: 10.1080/13547500802445199. Biomarkers. 2008. PMID: 18830857 Clinical Trial.

5

Perspective on a pathogenesis and treatment of Alzheimer's disease.

Roses AD, Saunders AM. Roses AD, et al. Alzheimers Dement. 2006 Apr;2(2):59-70. doi: 10.1016/j.jalz.2005.12.001. Alzheimers Dement. 2006. PMID: 19595857 No abstract available.

6

The importance of being connected.

Lutz MW, Crenshaw DG, Saunders AM, Roses AD. Lutz MW, et al. J Alzheimers Dis. 2011;24(2):247-51. doi: 10.3233/JAD-2010-101765. J Alzheimers Dis. 2011. PMID: 21206004 No abstract available.

7

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).

Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley RW. Roses AD, et al. Among authors: saunders am. Pharmacogenomics J. 2007 Feb;7(1):10-28. doi: 10.1038/sj.tpj.6500397. Epub 2006 Jun 13. Pharmacogenomics J. 2007. PMID: 16770341 Review.

8

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.

Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD; Rosiglitazone in Alzheimer's Disease Study Group. Risner ME, et al. Among authors: saunders am. Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54. doi: 10.1038/sj.tpj.6500369. Epub 2006 Jan 31. Pharmacogenomics J. 2006. PMID: 16446752 Clinical Trial.

9

Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer's disease.

Roses AD, Saunders AM. Roses AD, et al. Among authors: saunders am. Int Psychogeriatr. 1997;9 Suppl 1:277-88; discussion 317-21. doi: 10.1017/s1041610297005012. Int Psychogeriatr. 1997. PMID: 9447448

10

Analysis of European mitochondrial haplogroups with Alzheimer disease risk.

van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Murali Doraiswamy P, Gilbert JR, Haines JL, Vance JM, Pericak-Vance MA. van der Walt JM, et al. Among authors: saunders am. Neurosci Lett. 2004 Jul 15;365(1):28-32. doi: 10.1016/j.neulet.2004.04.051. Neurosci Lett. 2004. PMID: 15234467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

902 results

Search Page